Anika Therapeutics (ANIK) Share-based Compensation Growth (3y) (2013 - 2026)
Powered by 
Analysis
Anika Therapeutics (ANIK) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 8.37% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -22.92% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 19.64% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -28.31% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 0.55% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 4.11% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 7.30% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -0.59% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.40% |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn | 5.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.63% |
| Mar 31, 2026 | 52.90% |
| Dec 31, 2025 | -1.69% |
| Sep 30, 2025 | -18.70% |
| Jun 30, 2025 | -14.53% |
| Mar 31, 2025 | 24.72% |
| Dec 31, 2024 | -10.69% |
| Sep 30, 2024 | 5.84% |
| Jun 30, 2024 | 69.52% |
| Mar 31, 2024 | 1,203.04% |
| Dec 31, 2023 | 38.63% |
| Sep 30, 2023 | 22.86% |
| Jun 30, 2023 | 200.46% |
| Mar 31, 2023 | 122.24% |
| Dec 31, 2022 | -46.71% |
| Sep 30, 2022 | -43.03% |
| Jun 30, 2022 | 68.57% |
| Mar 31, 2022 | 575.90% |
| Dec 31, 2021 | 47.73% |
| Sep 30, 2021 | 34.49% |